BRAF inhibitor shows promising preclinical activity against melanoma
Wednesday, June 16, 2010 - 10:40
in Health & Medicine
Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032) inhibited proliferation of tumour cell lines that expressed V600E-BRAF, a mutation found in several human cancers, including melanoma...